Comerica Securities’s Organon & Co OGN Stock Holding History

Comerica Securities’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-424	Closed	-$11.8K	–	1100
2022 Q4	$11.8K	Buy	+424	New	+$10.8K	﹤0.01%	1004

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Comerica Securities's OGN Position: Q1 2023 in Review

Comerica Securities sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 424 shares — an estimated $11.8K sold.

Comerica Securities first reported a position in OGN in Q4 2022 and held it in 1 quarter. The position peaked at $11.8K in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

Comerica Securities reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 424 Organon & Co shares in Q1 2023, an estimated $11.8K.
Comerica Securities first reported a position in Organon & Co in Q4 2022 and held it in 1 quarter.
Comerica Securities's Organon & Co position peaked at $11.8K in Q4 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.